Abstract:The gut microbiota present in the human digestive system is incredibly varied and is home to trillions of microorganisms. The gut microbiome is shaped at birth, while numerous genetic, dietary, and environmental variables primarily influence the microbiome composition. The importance of gut microbiota on host health is becoming more widely acknowledged. Digestion, intestinal permeability, and immunological and metabolism responses can all be affected by changes in the composition and function of the gut microbiota. There is mounting evidence that the microbial population's complex traits are important biomarkers and indicators of patient outcomes in cancer and its therapies. Numerous studies have demonstrated that changed commensal gut microorganisms contribute to the development and spread of cancer through various routes. Despite the ongoing controversy surrounding the gut microbiome and gastrointestinal cancer, accumulating evidence points to a potentially far more intricate connection than a simple cause-and-effect relationship. SIMPLE SUMMARY: Due to their high frequency and fatality rate, gastrointestinal cancers are regarded as a severe public health issue with complex medical and economic burdens. The gut microbiota may directly or indirectly interact with existing therapies like immunotherapy and chemotherapy, affecting how well a treatment works. The gut microbiome influences the immune response's activity, function, and development. Generally, certain gut bacteria impact the antitumor actions during cancer by creating particular metabolites or triggering T-cell responses. Yet, certain bacterial species have been found to promote cellular proliferation and metastasis in cancer, and comprehending these interactions in the context of cancer may help identify possible treatment targets. Notwithstanding the improvements in the field, additional research is still required to comprehend the underlying processes, examine the effects on existing therapies, and pinpoint certain bacteria and immune cells that can cause this interaction.

The Gut Microbiome and Melanoma: a Review

Melanoma and microbiota: Current understanding and future directions

Interaction of the Gut Microbiome With Cancer Treatment

Microbial Influences on Immune Checkpoint Inhibitor Response in Melanoma: The Interplay between Skin and Gut Microbiota

The gut microbiome and efficacy of cancer immunotherapy

The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients

The Anti- and Pro-Tumorigenic Role of Microbiota and Its Role in Anticancer Therapeutic Strategies

The role of the gut microbiome in gastrointestinal cancers

Microbiota Alterations in Gastrointestinal Cancers

The gut microbiome modulate response to immunotherapy in cancer

Metastasis and the Microbiome: The Impact of Bacteria in Disseminated Colorectal Cancer

Gut microbiota: impacts on gastrointestinal cancer immunotherapy

Exploring the Role of the Gut and Intratumoral Microbiomes in Tumor Progression and Metastasis

Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy

Gut microbiome in gastrointestinal cancer: a friend or foe?

Gut Microbial Metabolites in Cancer Therapy

Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers

Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications

Gut microbiota and its therapeutic implications in tumor microenvironment interactions

Gut Microbiome Composition and Its Metabolites Are a Key Regulating Factor for Malignant Transformation, Metastasis and Antitumor Immunity

Intratumoural microbiota: from theory to clinical application